Chemotherapy-induced Peripheral Neuropathy
📧 Sign up to get email alerts when something new happens for Chemotherapy-induced Peripheral Neuropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-04-06Clinical Trial Update: Internet-delivered Management of Chemotherapy-Induced Peripheral Neuropathy (CIPN) [NA]
A clinical trial evaluating internet-delivered management of chemotherapy-induced peripheral neuropathy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-10-09Clinical Trial Update: Transcranial Direct Current Stimulation in Reducing Pain in Cancer Patients With Chemotherapy Induced Peripheral Neuropathy [EARLY_Phase 1]
A Phase 1 trial evaluating transcranial direct current stimulation to reduce pain in cancer patients with chemotherapy-induced peripheral ne…
-
CLINICAL_TRIALS withdrawal · 2024-08-09Clinical Trial Update: Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors [EARLY_Phase 1]
A Phase 1 trial evaluating phytocannabinoids for chemotherapy-induced peripheral neuropathy in breast and colon cancer survivors has been wi…
-
CLINICAL_TRIALS withdrawal · 2018-04-18Clinical Trial Update: Trial of Quercetin in the Treatment and Prevention of Chemotherapy-induced Neuropathic Pain in Cancer Patients [EARLY_Phase 1]
An early-phase trial investigating quercetin for chemotherapy-induced peripheral neuropathy in cancer patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-05-03Clinical Trial Update: Chemotherapy-Induced Peripheral Neuropathy Survey
A clinical trial evaluating chemotherapy-induced peripheral neuropathy has been withdrawn. The study involved patients with breast cancer, c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.